Results
Revise Search
-
Filters:
- All Records
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- 1987
- 1985
Non-medicinal ingredients in drug products
https://policybase.cma.ca/en/permalink/policy802
- Last Reviewed
- 2017-03-04
- Date
- 1985-08-25
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC85-28
- The Canadian Medical Association calls on Health Canada to facilitate the dissemination of information to health professionals and consumers concerning the presence, in drug products, of non-medicinal ingredients that can cause adverse reactions.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1985-08-25
- Resolution
- GC85-28
- The Canadian Medical Association calls on Health Canada to facilitate the dissemination of information to health professionals and consumers concerning the presence, in drug products, of non-medicinal ingredients that can cause adverse reactions.
- Text
- The Canadian Medical Association calls on Health Canada to facilitate the dissemination of information to health professionals and consumers concerning the presence, in drug products, of non-medicinal ingredients that can cause adverse reactions.
Adverse reactions between alcohol and drug products
https://policybase.cma.ca/en/permalink/policy805
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC87-31
- That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Resolution
- GC87-31
- That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
- Text
- That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Drug product substitution
https://policybase.cma.ca/en/permalink/policy806
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC87-39
- The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Resolution
- GC87-39
- The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
- Text
- The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.